Isoniazid Mediates the CYP2B6*6 Genotype-Dependent Interaction Between Efavirenz and Antituberculosis Drug Therapy Through Mechanism-Based Inactivation of CYP2A6
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02532-14
Full Text
Open PDFAbstract
Available in full text
Date
May 12, 2014
Authors
Publisher
American Society for Microbiology